L. Berres Jennifer's most recent trade in HCA Healthcare Inc was a trade of 5,378 Common Stock done at an average price of $322.3 . Disclosure was reported to the exchange on Feb. 13, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
HCA Healthcare Inc | Jennifer L. Berres | SVP & Chief Human Res. Officer | Sale of securities on an exchange or to another person at price $ 322.31 per share. | 13 Feb 2025 | 5,378 | 15,412 (0%) | 0% | 322.3 | 1,733,362 | Common Stock |
HCA Healthcare Inc | Jennifer L. Berres | SVP & Chief Human Res. Officer | Sale of securities on an exchange or to another person at price $ 322.95 per share. | 13 Feb 2025 | 4,155 | 20,790 (0%) | 0% | 323.0 | 1,341,878 | Common Stock |
HCA Healthcare Inc | Jennifer L. Berres | SVP & Chief Human Res. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 1,588 | 25,352 (0%) | 0% | 0 | Common Stock | |
HCA Healthcare Inc | Jennifer L. Berres | SVP & Chief Human Res. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 321.92 per share. | 13 Feb 2025 | 407 | 24,945 (0%) | 0% | 321.9 | 131,021 | Common Stock |
HCA Healthcare Inc | Jennifer L. Berres | SVP & Chief Human Res. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2025 | 7,440 | 0 | - | - | Stock Appreciation Right | |
HCA Healthcare Inc | Jennifer L. Berres | SVP & Chief Human Res. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 101.16 per share. | 07 Feb 2025 | 7,440 | 26,171 (0%) | 0% | 101.2 | 752,630 | Common Stock |
HCA Healthcare Inc | Jennifer L. Berres | SVP & Chief Human Res. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 322.05 per share. | 07 Feb 2025 | 6,747 | 23,764 (0%) | 0% | 322.0 | 2,172,871 | Common Stock |
HCA Healthcare Inc | Jennifer L. Berres | SVP & Chief Human Res. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 139.06 per share. | 07 Feb 2025 | 4,340 | 30,511 (0%) | 0% | 139.1 | 603,520 | Common Stock |
HCA Healthcare Inc | Jennifer L. Berres | SVP & Chief Human Res. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2025 | 4,340 | 0 | - | - | Stock Appreciation Right | |
HCA Healthcare Inc | Jennifer L. Berres | SVP & Chief Human Res. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 8,490 | 8,490 | - | - | Stock Appreciation Right | |
HCA Healthcare Inc | Berres Jennifer L. | SVP & Chief Human Res. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 9,420 | 21,971 (0%) | 0% | 0 | Common Stock | |
HCA Healthcare Inc | Berres L. Jennifer | SVP & Chief Human Res. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 308.55 per share. | 16 Feb 2024 | 3,240 | 18,731 (0%) | 0% | 308.6 | 999,702 | Common Stock |
HCA Healthcare Inc | L. Berres Jennifer | SVP & Chief Human Res. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 9,354 | 9,354 | - | - | Stock Appreciation Right | |
HCA Healthcare Inc | Jennifer L. Berres | SVP & Chief Human Res. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 7,600 | 14,992 (0%) | 0% | 0 | Common Stock | |
HCA Healthcare Inc | Jennifer L. Berres | SVP & Chief Human Res. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 262.84 per share. | 17 Feb 2023 | 2,441 | 12,551 (0%) | 0% | 262.8 | 641,592 | Common Stock |
HCA Healthcare Inc | Jennifer L. Berres | SVP & Chief Human Res. Officer | Sale of securities on an exchange or to another person at price $ 255.23 per share. | 07 Feb 2023 | 4,000 | 7,392 (0%) | 0% | 255.2 | 1,020,912 | Common Stock |
HCA Healthcare Inc | Jennifer L. Berres | SVP & Chief Human Res. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 10,735 | 10,735 | - | - | Stock Appreciation Right | |
HCA Healthcare Inc | Jennifer L. Berres | SVP & Chief Human Res. Officer | Sale of securities on an exchange or to another person at price $ 218.87 per share. | 13 May 2022 | 2,358 | 11,392 (0%) | 0% | 218.9 | 516,086 | Common Stock |
HCA Healthcare Inc | Jennifer L. Berres | SVP & Chief Human Res. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 6,200 | 16,577 (0%) | 0% | 0 | Common Stock | |
HCA Healthcare Inc | Jennifer L. Berres | SVP & Chief Human Res. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 244.10 per share. | 18 Feb 2022 | 2,827 | 13,750 (0%) | 0% | 244.1 | 690,071 | Common Stock |
HCA Healthcare Inc | Jennifer L. Berres | SVP & Chief Human Res. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 2,520 | 10,377 (0%) | 0% | 0 | Common Stock | |
HCA Healthcare Inc | Jennifer L. Berres | SVP & Chief Human Res. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2022 | 10,400 | 10,400 | - | - | Stock Appreciation Right | |
HCA Healthcare Inc | Jennifer Berres L. | SVP & Chief Human Res. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 248.27 per share. | 05 Nov 2021 | 6,163 | 7,857 (0%) | 0% | 248.3 | 1,530,088 | Common Stock |
HCA Healthcare Inc | Jennifer Berres L. | SVP & Chief Human Res. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 81.96 per share. | 05 Nov 2021 | 5,510 | 14,020 (0%) | 0% | 82.0 | 451,600 | Common Stock |
HCA Healthcare Inc | Jennifer Berres L. | SVP & Chief Human Res. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Nov 2021 | 5,510 | 0 | - | - | Stock Appreciation Right | |
HCA Healthcare Inc | Jennifer Berres L. | SVP & Chief Human Res. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Nov 2021 | 5,130 | 0 | - | - | Stock Appreciation Right | |
HCA Healthcare Inc | Jennifer Berres L. | SVP & Chief Human Res. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 69.58 per share. | 05 Nov 2021 | 5,130 | 8,510 (0%) | 0% | 69.6 | 356,945 | Common Stock |
HCA Healthcare Inc | Jennifer Berres L. | SVP & Chief Human Res. Officer | Sale of securities on an exchange or to another person at price $ 176.05 per share. | 18 Feb 2021 | 6,692 | 3,380 (0%) | 0% | 176.1 | 1,178,127 | Common Stock |
HCA Healthcare Inc | Jennifer Berres L. | SVP & Chief Human Res. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 3,306 | 11,373 (0%) | 0% | 0 | Common Stock | |
HCA Healthcare Inc | Jennifer Berres L. | SVP & Chief Human Res. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 174.61 per share. | 18 Feb 2021 | 1,301 | 10,072 (0%) | 0% | 174.6 | 227,168 | Common Stock |
HCA Healthcare Inc | Jennifer Berres L. | SVP & Chief Human Res. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 47.97 per share. | 16 Feb 2021 | 8,325 | 9,700 (0%) | 0% | 48.0 | 399,350 | Common Stock |
HCA Healthcare Inc | Jennifer Berres L. | SVP & Chief Human Res. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 174.00 per share. | 16 Feb 2021 | 7,633 | 8,067 (0%) | 0% | 174 | 1,328,142 | Common Stock |
HCA Healthcare Inc | Jennifer Berres L. | SVP & Chief Human Res. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2021 | 6,000 | 0 | - | - | Stock Appreciation Right | |
HCA Healthcare Inc | Jennifer Berres L. | SVP & Chief Human Res. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 68.96 per share. | 16 Feb 2021 | 6,000 | 15,700 (0%) | 0% | 69.0 | 413,760 | Common Stock |
HCA Healthcare Inc | Jennifer Berres L. | SVP & Chief Human Res. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2021 | 4,500 | 0 | - | - | Stock Appreciation Right | |
HCA Healthcare Inc | Jennifer Berres L. | SVP & Chief Human Res. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2021 | 3,825 | 0 | - | - | Stock Appreciation Right | |
HCA Healthcare Inc | Jennifer Berres L. | SVP & Chief Human Res. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 15,690 | 15,690 | - | - | Stock Appreciation Right |